MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.euf.2025.01.009

Медицинская библиотека · European urology focus · 2025

Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group.

Gallioli Andrea, Uleri Alessandro, Verri Paolo, Tedde Alessandro, Mertens Laura S, Moschini Marco, Del Giudice Francesco, Soria Francesco, Laukhtina Ekaterina, Subiela José Daniel, Krajewski Wojciech, D'Andrea David, Mari Andrea, Marcq Gautier, Mori Keiichiro, Teoh Jeremy, Afferi Luca, Albisinni Simone, Sanguedolce Francesco, Palou Joan, Breda Alberto, Pradere Benjamin, EAU-YAU Urothelial Working Group

Систематический обзорСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVE

Data about the mid- and long-term oncologic outcomes of endoscopic kidney-sparing surgery (eKSS) for upper tract urothelial carcinoma (UTUC) are scarce. Therefore, we aimed to summarize the current evidence on the oncologic outcomes of eKSS for UTUC.

METHODS

A literature search was conducted to identify reports published until May 2024. The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed to identify eligible studies. The outcomes were the following: recurrence-free (RFS), intravesical recurrence-free (IV-RFS), progression-free (PFS), cancer-specific (CSS), and overall (OS) survival.

KEY FINDINGS AND LIMITATIONS: We found 56 studies (n = 52 retrospective) that met our inclusion criteria (n = 2862 patients). The 1-, 2-, 5-, and 10-yr OS rates were 96%, 87%, 80%, and 42%, respectively. The 1-, 2-, 5-, and 10-yr CSS rates were 97%, 89%, 82%, and 69%, respectively. RFS rates at 1, 2, and 5 yr were 69%, 55%, and 45%, respectively. IV-RFS rates at 1, 2, and 5 yr were 80%, 65%, and 64%, respectively. PFS rates at 2 and 5 yr were 75% and 69%, respectively. In low-grade UTUC, OS rates at 2 and 5 yr were 93% and 77%, respectively. The 2- and 5-yr CSS rates were 98% and 88%, respectively. At 2 yr, RFS, IV-RFS, and PFS were 52%, 54%, and 94%, respectively. For high-grade UTUC, only three studies reported data on 2-yr RFS, which was 34%. The main limitation is the heterogeneity found across the studies.

CONCLUSIONS AND CLINICAL IMPLICATIONS: Local recurrence, bladder recurrence, and progression of UTUC occur mainly within 2 yr after eKSS. After 5-yr follow-up, OS and CSS drop, while the risk of local recurrence is non-negligible.

Для цитирования: Gallioli Andrea, Uleri Alessandro, Verri Paolo, Tedde Alessandro, Mertens Laura S, Moschini Marco, Del Giudice Francesco, Soria Francesco, Laukhtina Ekaterina, Subiela José Daniel, Krajewski Wojciech, D'Andrea David, Mari Andrea, Marcq Gautier, Mori Keiichiro, Teoh Jeremy, Afferi Luca, Albisinni Simone, Sanguedolce Francesco, Palou Joan, Breda Alberto, Pradere Benjamin, EAU-YAU Urothelial Working Group. Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group.. European urology focus. 2025. DOI: 10.1016/j.euf.2025.01.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.